Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (285) clinical trials

Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong

Atopic dermatitis (AD), atopic eczema or eczema, is a very common, highly pruritic chronic inflammatory skin disorder. The intense itching, sleep disturbance, coupled with visible rashes, causes immense physical, psychological, economical and social implications. Not only does it impact on the quality of life of the patient, caregivers are also ...

Phase N/A

Food Allergen OIT for Shrimp and Cashew

The site will enroll 72 participants, ages 12 to 55 years with an allergy to either cashew, or shrimp determined by DBPCFC, allergy history, clinical symptoms, food-allergen (FA)-specific IgE levels, and skin prick test (SPT). OIT treatment groups will be cashew (n=36), or shrimp (n=36). The subject's allergen will be ...

Phase

Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge

The primary objective is to evaluate the prophylactic efficacy of REGN1908-1909 (anti-Fel d administered as a single dose on day 1 in cat-allergic asthmatic patients not living with a cat in the prevention of a Controlled Cat Allergen Challenge-induced early asthmatic response (EAR) assessed by measures of lung function (FEV1) ...

Phase

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

The study will consist of a 30-day Screening period, a 7-day Run-In period, a 12-week Placebo-Controlled Treatment period followed by a 4-week Active Extension period and a Follow Up visit approximately 7 days after the last dose of study drug. All subjects will sign an informed consent form (ICF) and ...

Phase

Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)

The study will aim for a sample size of approximately 150 participants (equally distributed between 3 international sites) between the ages of 3 months and 5 years referred to the respective Dermatology Departments for management of moderate to severe atopic dermatitis. They will be sequentially recruited and randomized to the ...

Phase N/A

Oral Immunotherapy for Desensitization in Children Adolescents and Young Adults With Hen Egg Allergy

This is a phase 2, randomized, double-blind, placebo-controlled study of the efficacy and safety of AR201 in a CODIT regimen in hen egg-allergic subjects aged 4 to 26 years, inclusive. The study will be conducted at approximately 15 sites in the United States.

Phase

Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site

This is a protocol for prescreening of participants who would like to be in clinical studies in our Center at Stanford.

Phase N/A

Immune and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy

The primary objective of this study is to determine whether allowing ingestion of sub-threshold amounts of peanut in those with a high threshold (tolerate at least 143 mg peanut protein on supervised double-blind, placebo-controlled oral food challenge [DBPCFC]) will be associated with attaining even higher thresholds over time in children ...

Phase

Understanding and Diagnosing Allergic Disease in Twins

The purpose of this study is to study the genetic control and gain better understanding of how the immune system works in twins with and without allergic disease. Although healthy volunteers are not specifically targeted, they might be identified when non-allergic study participants are found through the course of evaluation ...

Phase N/A

Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults Adolescents and Children

This is a multi-center, open-label trial to evaluate safety and pharmacokinetics of topical delgocitinib cream applied to pediatric subjects(2-17 years) and adult subjects (18 years and above) with atopic dermatitis.

Phase